• Home
    • Concept
  • Program
    • Speakers
  • CardioMedLive
  • Livestream
  • On-demand
  • 2022 Symposia
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration
info@medupdate-europe.eu
Login

Login
Cardio Update Europe 2023Cardio Update Europe 2023
Cardio Update Europe 2023
30 June - 1 July - Vienna & Virtual
  • Home
    • Concept
  • Program
    • Speakers
  • CardioMedLive
  • Livestream
  • On-demand
  • 2022 Symposia
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration

Partners

Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. Daiichi Sankyo provides innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, the company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
www.daiichi-sankyo.eu

Transparency Notes

Daiichi Sankyo supports the Cardio Update Europe 2022 as a Partner.

Medtronic is the global leader medical technology, alleviating pain, restoring health an extending life for millions of people around the world. With deep roots in the treatment of heart disease, Medtronic now provides a wide range of products and therapies - every three seconds, another life is improved by a Medtronic product or therapy.
www.medtronic.com

Transparency Notes

Medtronic supports the Cardio Update Europe 2022 as a Partner.

Boehringer Ingelheim is driven by the desire to serve humankind by improving human and animal health. As a successful, family owned company BI plans in generations. They work together globally and with integrity.
www.boehringer-ingelheim.com

Transparency Notes

Boehringer Ingelheim supports the Cardio Update Europe 2022 as a Partner.

Servier is specialized in medicinal products. The primary focus is and always has been researching, developing, fine-tuning, and marketing innovative therapeutics, also known as brand-name medicines.
www.servier.com

Transparency Notes

Servier supports the Cardio Update Europe 2022 as a Partner.

At Janssen, they're creating a future where disease is a thing of the past. They’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. They focus on areas of medicine where they can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology and Pulmonary Hypertension.
www.janssen.com

Transparency Notes

Janssen supports the Cardio Update Europe 2022 as a Partner.
In cooperation with

Accreditation

The Cardio Update Europe 2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 10 European CME credits (ECMEC®s).

Accreditation – EFPIA & Ethical Medtech

The Cardio Update Europe 2023 has been assessed COMPLIANT by The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the MedTech Europe Code of Ethical Business Practice.

Follow us

Newsletter Subscription

Click here to receive news about your interest area. Unsubscribe at any time.

ethical medtech

www.ethicalmedtech.eu

© 2023

  • Home
  • Legal Notice
  • Data Privacy Policy
  • Contacts
  • Cookie policy (EU)
Manage Cookie Consent
We use cookies to optimize our website and our service. Please choose, which kind of cookies you'd like to accept.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}